RAJNISH logo

Rajnish Wellness Ltd

RAJNISH·BSE·
₹0.37▲ +0.00 (+0.00%)
Market Cap36.55 Cr
PE Ratio37.00
Volume15,02,990
Day High - Low0.37 - 0.36
52W High-Low0.90 - 0.34

Rajnish Wellness Ltd (RAJNISH): company summary

The company's revenue surged 189.3% annually, driven by a sharp jump in the latest quarter, but net profit swung to a loss of ₹6 crore, reversing a prior year profit.

Rajnish Wellness Ltd (RAJNISH) is a micro-cap Healthcare company valued at ₹37 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Rajnish Wellness Ltd last traded at ₹0.37, unchanged on the day.
Recent developments
On 2026-06-30, the company reported a net loss of ₹6 crore for the fiscal year ending March 2026, marking a reversal from the prior year's profit. In the latest quarter, revenue hit ₹31 crore, up 580.0% from ₹5 crore a year earlier, but net profit stayed at ₹0 crore, unchanged from the same quarter last year.
Financial performance
The company's revenue surged 189.3% annually, driven by a sharp jump in the latest quarter, but net profit swung to a loss of ₹6 crore, reversing a prior year profit. The latest quarter revenue rose 580.0% compared to the same quarter a year earlier, while net profit remained flat at ₹0 crore.
Valuation multiples
The stock trades at 37.0 times earnings, a premium to the Healthcare median of 32.0, 0.39 times book value.
Things to watch
The company reported a net loss of ₹6 crore in the latest financial year, reversing a prior year profit. Net profit margin deteriorated to -4.4%, down 4.4 percentage points from 0.0%. Return on equity and return on capital employed are both negative, indicating poor profitability.
Where it stands
Rajnish Wellness Ltd ended its latest financial year with a net loss of ₹6 crore, reversing a prior year profit, while revenue grew 189.3% annually. The latest quarter saw revenue jump 580.0% compared to the same quarter a year earlier, but net profit remained flat at ₹0 crore. The company's net profit margin is now -4.4%, and returns on equity and capital employed are negative.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
2.7/10
Poor
Fair Value
Sign in to see
ROE
-6.13%
Weak
P/E
37.00x
Expensive
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day₹0.36
₹0.37
52W₹0.34
₹0.90
DocStoX take

Supported by growth (7.5) and valuation (6.0), but held back by momentum (0.0). Growth looks strong at 7.5, but that is offset by momentum at 0.0 and quality at 0.3. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
2.7
/10
Poor
Quality
Weak
ROE -6.1%
Valuation
Fair
P/E 37.0×
Growth
Strong
Revenue +61.3% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Weak
5% of 52-week range

At a glance

Market Cap
₹37 Cr
52W High / Low
₹1 / ₹0
Dividend Yield
0.00%
Promoter Holding
9.16%
EPS (TTM)
₹0.01
Book Value
₹1.01

Key highlights

  • Revenue compounding 61% a year
  • Low leverage — D/E 0.00
  • Loss-making in some of the last 5 years
  • Quality is weak (0.3/10)
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Rajnish Wellness Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.